|
Other issues |
Leading articles
Who has the answers?
PJ 2010;284:202
Welcome to our new patient safety series
PJ 2010;284:202
News feature
Talk frequently and focus on patients: building bridges into general practice
PJ 2010;284:208-209
Products
Product news
PJ 2010;284:210
Glycopyrronium
PJ 2010;284:210
Metoject
PJ 2010;284:210
VMD website
PJ 2010;284:210
Letters
Letters for 27 February
PJ 2010;284:211-213
Agenda
Support for specialist and advanced practice and recognising the differences
PJ 2010;284:214-215
My career
Working across industry and the NHS
PJ 2010;284:216
Learning and development
Safe medication practice (series)
What do we know about the risk and harm associated with insulin?
PJ 2010;284:217
Focus on renal medicine
Pharmacy Professional p35 (March 2010
OTC tamsulosin
Pharmacy Professional p35 (March 2010)
CPD: Understanding essential tremor
Pharmacy Professional p36-40 (March 2010)
Articles
Pharmacists combating HIV/AIDS in developing Commonwealth countries
PJ 2010;284:218-220
Didapper
A celebration of rhubarb
PJ 2010;284:221
Measuring microfortnights and megafurlongs
PJ 2010;284:221
Did Chopin have CF?
PJ 2010;284:221
PJ business insight
Boosting pharmacy sales — are you asking the right questions?
PJ 2010:online
Santander offers a new banking option for pharmacy businesses
PJ 2010:online
